Pure Biologics S.A. PUR.WA Stock
Pure Biologics S.A. Price Chart
Pure Biologics S.A. PUR.WA Financial and Trading Overview
| Pure Biologics S.A. stock price | 8.3 PLN |
| Previous Close | 17.1 PLN |
| Open | 17.74 PLN |
| Bid | 17.08 PLN x N/A |
| Ask | 17.1 PLN x N/A |
| Day's Range | 17.38 - 17.38 PLN |
| 52 Week Range | 16.04 - 51.7 PLN |
| Volume | 2 PLN |
| Avg. Volume | 6.99K PLN |
| Market Cap | 55.86M PLN |
| Beta (5Y Monthly) | 1.456065 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -11.1 PLN |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
PUR.WA Valuation Measures
| Enterprise Value | 69.42M PLN |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 96.809906 |
| Price/Book (mrq) | 1.8696214 |
| Enterprise Value/Revenue | 120.31 |
| Enterprise Value/EBITDA | -3.09 |
Trading Information
Pure Biologics S.A. Stock Price History
| Beta (5Y Monthly) | 1.456065 |
| 52-Week Change | -62.084% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 51.7 PLN |
| 52 Week Low | 16.04 PLN |
| 50-Day Moving Average | 17.49 PLN |
| 200-Day Moving Average | 25.69 PLN |
PUR.WA Share Statistics
| Avg. Volume (3 month) | 6.99K PLN |
| Avg. Daily Volume (10-Days) | 4.78K PLN |
| Shares Outstanding | 3.21M |
| Float | 2.39M |
| Short Ratio | N/A |
| % Held by Insiders | 32.65% |
| % Held by Institutions | 19.24% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | -4426.17% |
| Gross Margin | 0% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -26.19% |
| Return on Equity (ttm) | -82.028% |
Income Statement
| Revenue (ttm) | 577K PLN |
| Revenue Per Share (ttm) | 0.24 PLN |
| Quarterly Revenue Growth (yoy) | -74.59% |
| Gross Profit (ttm) | -5407000 PLN |
| EBITDA | -22466000 PLN |
| Net Income Avi to Common (ttm) | -26287000 PLN |
| Diluted EPS (ttm) | -10.96 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 18.39M PLN |
| Total Cash Per Share (mrq) | 5.72 PLN |
| Total Debt (mrq) | 30.72M PLN |
| Total Debt/Equity (mrq) | 102.84 PLN |
| Current Ratio (mrq) | 2.292 |
| Book Value Per Share (mrq) | 9.296 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -25124000 PLN |
| Levered Free Cash Flow (ttm) | -19584500 PLN |
Profile of Pure Biologics S.A.
| Country | Poland |
| State | N/A |
| City | Wroclaw |
| Address | ul. Dunska 11 |
| ZIP | 54-427 |
| Phone | 48 795 61 18 11 |
| Website | https://purebiologics.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 72 |
Pure Biologics Spólka Akcyjna, a biopharmaceutical company, engages in the research and development of biological drugs and non-systematic therapies in the field of immuno-oncology, autoimmunology, and rare neurological diseases. It is involved in the production, purification, analysis, and characterization of antibodies and aptamers; and design, development, and validation of assays, as well as conducts research on technology platforms for selecting active molecules. The company offers PureApta, a modular platform for in vitro selection of modified aptamers for therapeutic and diagnostic use. It also engages in the development of non-systemic therapies for use in treating patients suffering from neurological autoimmune disorders, including neuromyelitis optica and myasthenia gravis; and provides contract research for pharmaceutical and biotechnology companies. Pure Biologics Spólka Akcyjna was incorporated in 2010 and is headquartered in Wroclaw, Poland.
Q&A For Pure Biologics S.A. Stock
What is a current PUR.WA stock price?
Pure Biologics S.A. PUR.WA stock price today per share is 8.3 PLN.
How to purchase Pure Biologics S.A. stock?
You can buy PUR.WA shares on the Warsaw exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Pure Biologics S.A.?
The stock symbol or ticker of Pure Biologics S.A. is PUR.WA.
Which industry does the Pure Biologics S.A. company belong to?
The Pure Biologics S.A. industry is Biotechnology.
How many shares does Pure Biologics S.A. have in circulation?
The max supply of Pure Biologics S.A. shares is 3.21M.
What is Pure Biologics S.A. Price to Earnings Ratio (PE Ratio)?
Pure Biologics S.A. PE Ratio is now.
What was Pure Biologics S.A. earnings per share over the trailing 12 months (TTM)?
Pure Biologics S.A. EPS is -11.1 PLN over the trailing 12 months.
Which sector does the Pure Biologics S.A. company belong to?
The Pure Biologics S.A. sector is Healthcare.